Skip to main content
logo
Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · Real-Time Price · USD
4.210
-0.025 (-0.59%)
Aug 7, 2025, 4:00 PM - Market closed

MorphoSys AG Revenue

Aurora Cannabis had revenue of 98.02M CAD in the quarter ending June 30, 2025, with 17.48% growth. This brings the company's revenue in the last twelve months to 357.88M, up 28.58% year-over-year. In the fiscal year ending March 31, 2025, Aurora Cannabis had annual revenue of 343.29M with 27.32% growth.

Revenue (ttm)
357.88M CAD
Revenue Growth
+28.58%
P/S Ratio
0.90
Revenue / Employee
333,533 CAD
Employees
1,073
Market Cap
237.18M USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025343.29M73.66M27.32%
Mar 31, 2024269.64M45.83M20.48%
Mar 31, 2023223.80M2.47M1.11%
Jun 30, 2022221.34M-23.91M-9.75%
Jun 30, 2021245.25M-23.45M-8.73%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Novo Nordisk49.11B
Eli Lilly and Company49.00B
Revenue Rankings

ACB News

More News